Evidence map›Paper›PMID 33553123›Full record

ReviewFrontiers in bioengineering and biotechnology2020

Developing a Sustainable and Circular Bio-Based Economy in EU: By Partnering Across Sectors, Upscaling and Using New Knowledge Faster, and For the Benefit of Climate, Environment & Biodiversity, and People & Business.

Lene Lange, Kevin O Connor, Sigurjon Arason, Uffe Bundgård-Jørgensen, Antonella Canalis, Dirk Carrez, Joe Gallagher, Niels Gøtke, Christian Huyghe, Bruno Jarry and 10 more

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Bioactive Potential of Sweet Cherry (Foods (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. A Novel Bio-Purification Process Employing an EngineeredBioengineering (Basel, Switzerland) · 2024
    Article
  11. Engineered microbial consortia for next-generation feedstocks.Biotechnology notes (Amsterdam, Netherlands) · 2024
    Article
  12. Optimization of a hybrid bacterial/Metabolic engineering communications · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Bioeconomy and green recovery in a post-COVID-19 era.The Science of the total environment · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Lene LangeBioEconomy, Research and Advisory, Copenhagen, Denmark.
Kevin O ConnorBiOrbic SFI Bioeconomy Research Centre, School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Sigurjon ArasonFaculty of Food Science and Nutrition in the University of Iceland and Matis ohf, Reykjavík, Iceland.
Uffe Bundgård-JørgensenGate2Growth, DTU Science Park, Kongens Lyngby, Denmark.
Antonella CanalisBio-based Industries Joint Undertaking (BBI JU), Brussels, Belgium.
Dirk CarrezBio-based Industries Consortium (BIC), Brussels, Belgium.
Joe GallagherInstitute of Biological, Environmental and Rural sciences (IBERS), Aberystwyth University, Aberystwyth, United Kingdom.
Niels GøtkeMinistry of Science, Innovation and Higher Education of Denmark, Copenhagen, Denmark.
Christian HuygheScientific Director Agriculture, INRAE, Paris, France.
Bruno JarryNational Academy of Technology of France, Paris, France.
Pilar LlorenteBio-based Industries Joint Undertaking (BBI JU), Brussels, Belgium.
Mariya MarinovaDepartment of Chemistry and Chemical Engineering, Royal Military College of Canada, Kingston, ON, Canada.
Ligia O MartinsInstituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.
Philippe MengalBio-based Industries Joint Undertaking (BBI JU), Brussels, Belgium.
Paola PaianoBio-based Industries Joint Undertaking (BBI JU), Brussels, Belgium.
Calliope PanoutsouCentre for Environmental Policy, Imperial College London, London, United Kingdom.
Ligia RodriguesCentre of Biological Engineering, University of Minho, Campus de Gualtar, Braga, Portugal.
Dagmar B StengelBotany and Plant Science, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland.
Yvonne van der MeerAachen Maastricht Institute for Biobased Materials, Maastricht University, Brightlands Chemelot Campus, Geleen, Netherlands.
Helena VieiraDirectorate General of Maritime Policy, Ministry of the Sea, and BioISI - Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper gives an overview of development of the EU-bioeconomy, 2014-2020. The Vision of the new Circular Bio-based Economy, CBE is presented: Unlocking the full potential of all types of sustainably sourced biomass, crop residues, industrial side-streams, and wastes by transforming it into value-added products. The resulting product portfolio consists of a wide spectrum of value-added products, addressing societal and consumer needs. Food and feed, bio-based chemicals, materials, health-promoting products; and bio-based fuels. The pillars of CBE are described, including biotechnology, microbial production, enzyme technology, green chemistry, integrated physical/chemical processing, policies, conducive framework conditions and public private partnerships. Drivers of CBE are analyzed: Biomass supply, biorefineries, value chain clusters, rural development, farmers, foresters and mariners; urgent need for climate change mitigation and adaptation, and stopping biodiversity loss. Improved framework conditions can be drivers but also obstacles if not updated to the era of circularity. Key figures, across the entire BBI-JU project portfolio (2014-2020) are provided, including expansion into biomass feedstocks, terrestrial and aquatic, and an impressive broadening of bio-based product portfolio, including higher-value, health-promoting products for man, animal, plants and soil. Parallel to this, diversification of industrial segments and types of funding instruments developed, reflecting industrial needs and academic research involvement. Impact assessment is highlighted. A number of specific recommendations are given; e.g., including international win/win CBE-collaborations, as e.g., expanding African EU collaboration into CBE. In contrast to fossil resources biological resources are found worldwide. In its outset, circular bio-based economy, can be implemented all over, in a just manner, not the least stimulating rural development.

Indexed as

Biobased Industries Consortium (BIC)Bio-Based Industries Joint Undertaking (BBI-JU)bio-based productsbiorefinery technologiesCircular Bio-based Economy (CBE)microbial productionside-streams & wastesupgrading

Identifiers

PMID33553123
PMCPMC7860146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.